Advertisement
Tin tức Forex
Mirum Pharma Says EMBARK Phase 2b Study Evaluating LIVMARLI Fails To Meet Endpoints
Mirum Pharmaceuticals, Inc. (MIRM) announced Monday top-line results of the Phase 2 EMBARK study evaluating LIVMARLI (maralixibat) oral solution versus placebo given as an adjuvant therapy to Kasai surgery in patients with biliary atresia.
RTTNews |
604 ngày trước
Consolidated Communications Urges Shareholders To Vote FOR Proposed Deal With Searchlight And BCI
Consolidated Communications Holdings, Inc. (CNSL) announced Monday it has filed its definitive proxy statement. The Company has also filed a letter to shareholders in connection with its upcoming special meeting of shareholders urging shareholders to vote "FOR" the proposed acquisition of the Company by affiliates of Searchlight Capital Partners, L.P. and British Columbia Investment Management Corporation.
RTTNews
|
604 ngày trước
Pound Weakens On Rate Uncertainty
The pound fell against its most major counterparts in the European session on Monday, weighed by New York Fed President John Williams' remarks that policymakers "aren't really talking about rate cuts right now".
RTTNews
|
604 ngày trước
Molina Amends Purchase Price For Acquisition Of Bright HealthCare's California Medicare Business
Molina Healthcare, Inc. (MOH) announced Monday that last week it amended the purchase agreement for the acquisition of Bright HealthCare's California Medicare business.
RTTNews
|
604 ngày trước
BoE's Broadbent: Further Evidence Needed To Conclude Downward Trend In Wage Growth
Further evidence is required to conclude that wage growth is cooling, and for the Bank of England to consider interest rate cuts, Deputy Governor Ben Broadbent said Monday. There is a little more uncertainty than usual about the behavior of unemployment, Broadbent said in a speech at the London Business School.
RTTNews
|
604 ngày trước
Novavax Says Taiwan Grants EUA For Nuvaxovid XBB.1.5 Dispersion For Injection COVID-19 Vaccine
Novavax, Inc. (NVAX) announced Monday that the Taiwan Food and Drug Administration has granted emergency use authorization for Nuvaxovid XBB.1.5 dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) for active immunization to prevent COVID-19 in individuals aged 12 and older.
RTTNews
|
604 ngày trước
Dollar Tumbled Last Week Amidst Hints Of Fed's Policy Pivot
The U.S. Dollar tumbled during the week spanning December 8-15 amidst the Fed's dovish pivot that provided hints of rate cuts in 2024.
RTTNews
|
604 ngày trước
more news
German Business Confidence Unexpectedly Deteriorates
Sentiment among German companies deteriorated at the end of the year, providing more evidence that the economy is mired in a recession, results of a key survey showed Monday. The business climate index fell to 86.4 in December from a revised score of 87.2 in the previous month, survey results from the Munich-based ifo Institute revealed. The score was forecast to improve to 87.8.
RTTNews
|
604 ngày trước
Lexeo Therapeutics Says FDA Grants Fast Track And Orphan Drug Designation To LX2020
Genetic medicine company Lexeo Therapeutics, Inc. (LXEO) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation and Orphan Drug designation to LX2020.
RTTNews
|
604 ngày trước
U.S. Dept. Of Transportation Fines Southwest Airlines $140 Mln For Operational Violations
The U.S. Department of Transportation issued on Monday a consent order for violations of consumer protection laws by Southwest Airlines Co. (LUV) during and after the operational failures that stranded over two million passengers over the 2022 Christmas holiday and into the New Year.
RTTNews
|
604 ngày trước
HLS Therapeutics CFO Tim Hendrickson Steps Down; Names Director John Hanna Interim CFO
Pharmaceutical company HLS Therapeutics Inc. (HLS.TO) announced Monday that Tim Hendrickson is stepping down as CFO to pursue other interests and John Hanna, currently a director of the Company, has been appointed Interim CFO.
RTTNews
|
604 ngày trước
Catalyst Pharma Says FIRDAPSE NDA Submitted In Japan By Partner DyDo Pharma
Biopharmaceutical company Catalyst Pharmaceuticals, Inc. (CPRX) announced Monday that its collaboration partner, Japan's DyDo Pharma, Inc., reported that it has submitted a New Drug Application (NDA) to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, seeking marketing approval for FIRDAPSE (amifampridine) Tablets 10 mg for the treatment of Lambert Eaton myasthenic syndrome (LEMS) in Japan.
RTTNews
|
604 ngày trước
Yen Falls Ahead Of BoJ Policy Decision
The Japanese yen weakened against other major currencies in the European session on Monday, as traders cautiously await the Bank of Japan's final monetary policy meeting of the year later in the week, with the central bank expected to maintain its ultra-dovish stance.
RTTNews
|
604 ngày trước
Stay up to date!
Add Tin tức to your browser
Add To Chrome
